Sarolaner
CAS No. 1398609-39-6
Sarolaner( PF-6450567 )
Catalog No. M23553 CAS No. 1398609-39-6
Sarolaner is an orally active and broad-spectrum ectoparasiticide (LC80: 0.3 μg/mL against C. felis and an LC100: 0.003 μg/mL against O. turicata).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 128 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 169 | In Stock |
|
| 25MG | 359 | In Stock |
|
| 50MG | 528 | In Stock |
|
| 100MG | 758 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSarolaner
-
NoteResearch use only, not for human use.
-
Brief DescriptionSarolaner is an orally active and broad-spectrum ectoparasiticide (LC80: 0.3 μg/mL against C. felis and an LC100: 0.003 μg/mL against O. turicata).
-
DescriptionSarolaner is an orally active and broad-spectrum ectoparasiticide (LC80: 0.3 μg/mL against C. felis and an LC100: 0.003 μg/mL against O. turicata).
-
In VitroCell Viability Assay Cell Line:CHO-K1 cell lines Concentration:450 nM-1 mM Incubation Time:5 min Result:Inhibited GABA-elicited currents at both susceptible (CfRDL-A285) and resistant (CfRDL-S285) flea GABACls with EC50s of 135 and 136 nM, respectively.
-
In VivoAnimal Model:Dog infested with R. sanguineus and D. reticulatus Dosage:2.5 mg/kg Administration:Oral gavage; 2.5 mg/kg once Result:Exibited 100% efficacy against R. sanguineus at 48 hours after treatment and also exhibited 98.0% efficacy against D. reticulatus.Animal Model:Dog infested with I. ricinus Dosage:1.25, 2.5 and 5 mg/kg Administration:Oral gavage; 1.25, 2.5 and 5 mg/kg once Result:Exibited 100% efficacy against I. ricinus at all doses until 7 days, and provided over 99.3% reduction against subsequent re-infestations until 57 days at dose of 5.0 and 2.5 mg/kg.
-
SynonymsPF-6450567
-
PathwayOthers
-
TargetOther Targets
-
RecptorLC80|LC100
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1398609-39-6
-
Formula Weight581.36
-
Molecular FormulaC23H18Cl2F4N2O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 290 mg/mL (498.83 mM; Need ultrasonic)
-
SMILESO=S(CC(N1CC2(OCC3=C2C=CC(C4=NO[C@](C(F)(F)F)(C5=CC(Cl)=C(F)C(Cl)=C5)C4)=C3)C1)=O)(C)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
4-Hydroxy-L-phenylgl...
4-Hydroxy-L-(+)-2-phenylglycine is a carnitine palmitoyltransferase-1 inhibitor. 4-Hydroxy-L-(+)-2-phenylglycine improves whole-body glucose tolerance and insulin sensitivity in high-fat diet-induced obese mouse with insulin resistance.
-
Anticonvulsant agent...
Anticonvulsant agent 2 is a potent, orally active anticonvulsant demonstrating antiepileptic activity in a drug-resistant epilepsy model.
-
Moth Cytochrome C (M...
Moth Cytochrome C (MCC) (88-103), derived from the carboxyl terminus of moth cytochrome c, induces positive selection of TCR transgenic thymocytes.This peptide is derived from the carboxyl terminus of moth cytochrome c. Thymic positive and negative selections govern the development of a self-MHC-reactive, yet self-tolerant, T cell repertoire.
Cart
sales@molnova.com